Raben David Insider Trading Activity
Raben David has been net-selling over the last 12 months with 0 purchases and 8 sales across 1 company.
BCAX is the most-traded position with 8 trades. The largest single transaction was a sale of BCAX for $406K on Oct 9, 2025.
Performance Scorecard
Forward stock performance after each transaction by Raben David. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +1.2% | 63% | 8 |
| 90 days | — | +4.0% | 67% | 6 |
| 120 days | — | +5.0% | 100% | 4 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersBCAX · Bicara Therapeutics Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Raben David bought and sold BCAX.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | ROLE |
|---|---|---|---|---|---|---|
| Apr 27, 2026 | BCAX | Sell | 5,500 | $22.88 | $126K | Chief Medical Officer |
| Mar 25, 2026 | BCAX | Sell | 5,500 | $18.95 | $104K | Chief Medical Officer |
| Mar 4, 2026 | BCAX | Sell | 16,300 | $18.52 | $302K | Chief Medical Officer |
| Mar 3, 2026 | BCAX | Sell | 200 | $18.45 | $4K | Chief Medical Officer |
| Nov 25, 2025 | BCAX | Sell | 906 | $18.84 | $17K | Chief Medical Officer |
| Nov 25, 2025 | BCAX | Sell | 4,594 | $18.84 | $87K | Chief Medical Officer |
| Nov 24, 2025 | BCAX | Sell | 5,500 | $18.45 | $101K | Chief Medical Officer |
| Oct 9, 2025 | BCAX | Sell | 22,000 | $18.45 | $406K | Chief Medical Officer |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | 8 | $1.1M |
Other insiders at Bicara Therapeutics Inc.
4 other tracked filers at BCAX.